151 related articles for article (PubMed ID: 19382664)
41. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
42. Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia.
Brayfield BP; Phiri S; Kankasa C; Muyanga J; Mantina H; Kwenda G; West JT; Bhat G; Marx DB; Klaskala W; Mitchell CD; Wood C
J Infect Dis; 2003 Feb; 187(4):559-68. PubMed ID: 12599072
[TBL] [Abstract][Full Text] [Related]
43. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
Tanzi E; Zappa A; Caramaschi F; Amendola A; Lasagna D; Gatti L; Ascoli V; Rezza G; Zanetti AR
J Med Virol; 2005 Aug; 76(4):571-5. PubMed ID: 15977229
[TBL] [Abstract][Full Text] [Related]
44. Seroprevalence of human herpesvirus 8 infection in Northern Thailand.
Chen N; Nelson KE; Jenkins FJ; Suriyanon V; Duerr A; Costello C; Robison V; Jacobson LP
Clin Infect Dis; 2004 Oct; 39(7):1052-8. PubMed ID: 15472860
[TBL] [Abstract][Full Text] [Related]
45. The seroprevalence of hepatitis A and B in people testing positive for hepatitis C.
Kiefer LA; Honish A; Predy G; Talbot JA
CMAJ; 2000 Jan; 162(2):207-8. PubMed ID: 10674054
[No Abstract] [Full Text] [Related]
46. Viral hepatitis in Bucharest.
Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.
Mayama S; Cuevas LE; Sheldon J; Omar OH; Smith DH; Okong P; Silvel B; Hart CA; Schulz TF
Int J Cancer; 1998 Sep; 77(6):817-20. PubMed ID: 9714046
[TBL] [Abstract][Full Text] [Related]
48. Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region.
de Souza VA; Sumita LM; Nascimento MC; Oliveira J; Mascheretti M; Quiroga M; Freire WS; Tateno A; Boulos M; Mayaud P; Pannuti CS
J Infect Dis; 2007 Sep; 196(6):844-52. PubMed ID: 17703414
[TBL] [Abstract][Full Text] [Related]
49. Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana.
Kazanji M; Dussart P; Duprez R; Tortevoye P; Pouliquen JF; Vandekerkhove J; Couppié P; Morvan J; Talarmin A; Gessain A
J Infect Dis; 2005 Nov; 192(9):1525-9. PubMed ID: 16206066
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
51. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
52. Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases.
Trento E; Castilletti C; Ferraro C; Lesnoni La Parola I; Mussi A; Muscardin L; Bordignon V; D'Agosto G; Amantea A; Mastroianni A; Ameglio F; Fluhr J; Cordiali-Fei P
Arch Dermatol; 2005 Oct; 141(10):1235-42. PubMed ID: 16230560
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon.
Rezza G; Tchangmena OB; Andreoni M; Bugarini R; Toma L; Bakary DK; Glikoutou M; Sarmati L; Monini P; Pezzotti P; Ensoli B
Sex Transm Dis; 2000 Mar; 27(3):159-64. PubMed ID: 10726650
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily.
Perna AM; Bonura F; Vitale F; Viviano E; Di Benedetto MA; Ajello F; Villafrate MR; Prestileo T; Mancuso S; Goedert JJ; Romano N
Int J Epidemiol; 2000 Feb; 29(1):175-9. PubMed ID: 10750620
[TBL] [Abstract][Full Text] [Related]
55. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.
Serraino D; Toma L; Andreoni M; Buttò S; Tchangmena O; Sarmati L; Monini P; Franceschi S; Ensoli B; Rezza G
Eur J Epidemiol; 2001; 17(9):871-6. PubMed ID: 12081107
[TBL] [Abstract][Full Text] [Related]
56. Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan.
Fujii T; Taguchi H; Katano H; Mori S; Nakamura T; Nojiri N; Nakajima K; Tadokoro K; Juji T; Iwamoto A
J Med Virol; 1999 Feb; 57(2):159-62. PubMed ID: 9892401
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China.
Zhang T; He N; Ding Y; Crabtree K; Minhas V; Wood C
Clin Microbiol Infect; 2011 Mar; 17(3):395-401. PubMed ID: 20545961
[TBL] [Abstract][Full Text] [Related]
58. Increased seroprevalence of human herpesvirus 8 in patients with hematological disorders.
Tsai WH; Lee YM; Ing-Tiau Kuo B; Ho CK; Liao PT; Liu MD; Kou YR; Hsu HC
Acta Haematol; 2005; 114(2):95-8. PubMed ID: 16103632
[TBL] [Abstract][Full Text] [Related]
59. Seroprevalence of human herpesvirus 8 in kidney transplant recipients in a single-center study from Tunisia.
Lahlaoui H; Niija H; Ben Moussa M
Iran J Kidney Dis; 2012 Jan; 6(1):14-6. PubMed ID: 22218113
[TBL] [Abstract][Full Text] [Related]
60. [Epidemiology of KSHV infection].
Mamiya N
Nihon Rinsho; 2006 Mar; 64 Suppl 3():613-6. PubMed ID: 16615545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
